Which companies are Cowealth Medical China's closest peers?

The cockpit's peer set: SunMax Biotechnology (4728.TWO), Xvivo Perfusion (XVIVO.ST), AK Medical (1789.HK), Beijing Chunlizhengda Medical Instruments (1858.HK), Hangzhou AGS MedTech (688581.SS), Jiangsu Hanvo Safety Product (300952.SZ), Japan Lifeline (7575.T), Ningbo David Medical Device (300314.SZ).

Is Cowealth Medical China expensive compared with its peers?

On ev / sales it trades at 6.8× against a peer median of 3.9×, 5th most expensive of 21 in its peer set.

How has Cowealth Medical China stock performed?

Over six months to 6 Nov 2026 the shares returned -27.9% against -11.8% for the median peer; over one year +69.5%.

← CockpitCompetitor Analysis › 603122.SS Cowealth Medical China Co., Ltd. Class AOpen in the cockpit ↗

Cowealth Medical China Co., Ltd. Class A603122.SSCompetitor analysis, valuation and peers

China · CNY·Health Care›Medical Specialties

Momentum weak 37

Competitor Analysis ▸ Charts Open in the cockpit

Mkt cap

$648M

US dollars, full cap

$/day

$39.6M

20-day average traded

Fwd P/E

n/m

no positive forecast

ROIC−WACC

-6.0 pp

WACC 5.0%

Hurdle

n/a

no reverse DCF

Close · CNYCN¥10.85

1D-2.1%

1W+3.1%

1M-20.0%

3M+0.3%

6M-27.9%

YTD-55.5%

1Y+69.5%

ATR %6.8%

52w lowhigh65.2% off high

What Cowealth Medical China does

Employees: 161

Cowealth Medical China at a glance

Size Cowealth Medical China (603122.SS) is a China Health Care company (Medical Specialties) with a market value of $648M, the 3244th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥10.85 on 6 Nov 2026.

Performance Over six months the shares fell 27.9%, against -11.8% for the median peer and -16.4% for the China market (cap-weighted) — 4th lowest of 21 in its peer set.

Growth Revenue fell 17.6% over the last twelve months (peer median +9.5%); the operating margin is -5.3% (peer median 10.4%).

Valuation It trades at 6.8× enterprise value to sales against a peer median of 3.9× (5th most expensive of 21).

Capital Return on invested capital runs 6.0 points below its cost of capital (5.0% WACC).

Relative performance

Six months, rebased to 100: Cowealth Medical China against the median of its 20 peers (local-currency closes).

Cowealth Medical China financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
	TTM	FY2025	FY2024	FY2023	FY2022
Revenue	CN¥640M	CN¥677M	CN¥937M	CN¥1.09B	CN¥1.28B
Revenue growth	—	-28%	-14%	-15%	—
Gross profit	CN¥121M	CN¥89.2M	CN¥172M	CN¥214M	CN¥245M
EBITDA	n/a	-CN¥16.7M	CN¥49.8M	CN¥73.6M	CN¥122M
Net income	-CN¥26.9M	-CN¥33.6M	CN¥27.6M	CN¥47.2M	CN¥82.7M
Free cash flow	-CN¥76.9M	CN¥6.19M	CN¥103M	-CN¥57.2M	-CN¥54.3M
Capital expenditure	CN¥11.7M	CN¥14.2M	CN¥31.8M	CN¥68.0M	CN¥25.9M
Total debt	CN¥188M	CN¥170M	CN¥122M	CN¥72.2M	CN¥140M

Quarterly statements and history in the cockpit →

Cowealth Medical China competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

Up and to the right = strong over both horizons. Cowealth Medical China is the large dot.

Fundamentals: revenue growth against valuation

Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Cowealth Medical China is the large dot.

Cowealth Medical China competitors and peer comparison

How Cowealth Medical China compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Cowealth Medical China against its 20 peers (data as of 6 Nov 2026)
Measure	603122.SS	Peer median	Rank in peer set
1-month return	-20.0%	-0.5%	2nd lowest of 21
6-month return	-27.9%	-11.8%	4th lowest of 21
Distance from 52-week high	-65.2%	-32.9%	lowest of 21
Revenue growth (TTM)	-17.6%	+9.5%	3rd lowest of 21
Operating margin	-5.3%	10.4%	4th lowest of 21
EV / Sales	6.8×	3.9×	5th most expensive of 21
ROIC minus cost of capital	-6.0 pp	+1.7 pp	4th lowest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
Company	Market	Market cap	6M return	Revenue growth	Op. margin	EV / Sales	Req g	Delivered g
Cowealth Medical China 603122.SS	China	$648M	-28%	-18%	-5%	6.8×	n/a	n/a
SunMax Biotechnology 4728.TWO	Taiwan	$643M	+1%	+12%	50%	9.4×	-0.7%	+18.8%
Xvivo Perfusion XVIVO.ST	Sweden	$635M	-29%	+18%	12%	6.3×	35.7%	+35.2%
AK Medical 1789.HK	Hong Kong	$664M	-26%	+16%	26%	2.2×	-11.4%	+6.7%
Beijing Chunlizhengda Medical Instruments 1858.HK	Hong Kong	$671M	-27%	-9%	31%	2.6×	-8.0%	+1.5%
Hangzhou AGS MedTech 688581.SS	China	$617M	-16%	-18%	33%	4.0×	1.7%	+27.8%
Jiangsu Hanvo Safety Product 300952.SZ	China	$681M	-21%	+6%	8%	3.8×	n/a	n/a
Japan Lifeline 7575.T	Japan	$685M	+16%	+6%	19%	1.6×	-9.7%	+2.9%
Ningbo David Medical Device 300314.SZ	China	$607M	+22%	+19%	11%	5.6×	n/a	n/a
Wuhan Huakang Century Clean Technology 301235.SZ	China	$603M	-42%	+28%	7%	1.7×	n/a	n/a
Shanghai Kinetic Medical 300326.SZ	China	$698M	-7%	-28%	17%	4.2×	8.1%	-1.9%
Medistim MEDI.OL	Norway	$601M	+30%	+19%	29%	6.8×	-1.8%	+14.5%
Contec Medical Systems 300869.SZ	China	$600M	-23%	-2%	-16%	6.3×	17.3%	-19.8%
Shanghai Sanyou Medical 688085.SS	China	$700M	-21%	+15%	4%	7.2×	29.1%	+6.8%
Nanosonics NAN.AX	Australia	$599M	-13%	+3%	7%	3.6×	34.4%	+6.7%
Pacific Biosciences of California PACB	United States	$701M	+60%	+2%	-102%	7.6×	n/a	n/a
Livsmed 491000.KS	South Korea	$706M	-47%	+89%	-59%	17.2×	n/a	n/a
Synektik SNT.WA	Poland	$713M	+16%	+50%	24%	3.0×	0.1%	+40.3%
Mesa Laboratories MLAB	United States	$718M	+23%	+3%	9%	3.4×	21.1%	+13.2%
Tactile Systems Technology TCMD	United States	$583M	+1%	+14%	9%	1.5×	7.8%	+12.0%
Zhejiang Gongdong Medical Technology 605369.SS	China	$581M	-10%	+6%	9%	2.8×	11.6%	+6.5%

Questions

Which companies are Cowealth Medical China's closest peers?: The cockpit's peer set: SunMax Biotechnology (4728.TWO), Xvivo Perfusion (XVIVO.ST), AK Medical (1789.HK), Beijing Chunlizhengda Medical Instruments (1858.HK), Hangzhou AGS MedTech (688581.SS), Jiangsu Hanvo Safety Product (300952.SZ), Japan Lifeline (7575.T), Ningbo David Medical Device (300314.SZ).
Is Cowealth Medical China expensive compared with its peers?: On ev / sales it trades at 6.8× against a peer median of 3.9×, 5th most expensive of 21 in its peer set.
How has Cowealth Medical China stock performed?: Over six months to 6 Nov 2026 the shares returned -27.9% against -11.8% for the median peer; over one year +69.5%.